Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy

BJU International

Volumn 111, Issue 1, 2013, Pages 74-84

  Rink, Michael ^a,b   Hansen, Jens ^b,c   Cha, Eugene K ^a   Green, David A ^a   Babjuk, Marko ^d   Svatek, Robert S ^e   Xylinas, Evanguelos ^a   Tagawa, Scott T ^a   Faison, Talia ^a   Novara, Giacomo ^f   Karakiewicz, Pierre I ^c   Daneshmand, Siamak ^g   Lotan, Yair ^h   Kassouf, Wassim ⁱ   Fritsche, Hans Martin ^j   Pycha, Armin ^k   Comploj, Evi ^k   Tilki, Derya ^l   Bastian, Patrick J ^l   Chun, Felix K ^b   Dahlem, Roland ^b   Scherr, Douglas S ^a   Shariat, Shahrokh F ^a   more..

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d CHARLES UNIVERSITY   (Czech Republic)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f UNIVERSITY OF PADOVA   (Italy)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h UNIVERSITY OF TEXAS AT DALLAS   (United States)

ⁱ MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^j UNIVERSITY OF REGENSBURG   (Germany)

^k CENTRAL HOSPITAL OF BOLZANO   (Italy)

^l UNIVERSITY OF MUNICH   (Germany)

more..

Author keywords

adjuvant chemotherapy; bladder cancer; lymph node metastasis; nomogram; radical cystectomy; survival; urothelial carcinoma

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; UROTHELIAL CARCINOMA OF THE BLADDER;

EID: 84871608722     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11356.x     Document Type: Article

References (34)

1. Madersbacher S, Hochreiter W, Burkhard F, et al. Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003; 21: 690-696
2. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666-675
3. Shariat SF, Ehdaie B, Rink M, et al. Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. Eur Urol 2012; 61: 237-242
4. Bochner BH, Kattan MW, Vora KC,. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol 2006; 24: 3967-3972
5. Karakiewicz PI, Shariat SF, Palapattu GS, et al. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. J Urol 2006; 176: 1354-1362
6. Shariat SF, Karakiewicz PI, Palapattu GS, et al. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res 2006; 12: 6663-6676
7. Bruins HM, Huang GJ, Cai J, Skinner DG, Stein JP, Penson DF,. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy. J Urol 2009; 182: 2182-2187
8. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF,. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002; 167: 1295-1298
9. Karl A, Carroll PR, Gschwend JE, et al. The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol 2009; 55: 826-835
10. Kassouf W, Svatek RS, Shariat SF, et al. Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder. Urol Oncol 2011; [Epub ahead of print]. DOI: 10.1016/j.urolonc.2011.02. 011
11. Konety BR, Joslyn SA, O'Donnell MA,. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J Urol 2003; 169: 946-950
12. Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN, Studer UE,. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol 2001; 166: 19-23
13. Stein JP, Cai J, Groshen S, Skinner DG,. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 2003; 170: 35-41
14. Vieweg J, Gschwend JE, Herr HW, Fair WR,. The impact of primary stage on survival in patients with lymph node positive bladder cancer. J Urol 1999; 161: 72-76
15. Calabro F, Sternberg CN,. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer. Eur Urol 2009; 55: 348-358
16. Gofrit ON, Stadler WM, Zorn KC, et al. Adjuvant chemotherapy in lymph node positive bladder cancer. Urol Oncol 2009; 27: 160-164
17. Park J, Park S, Song C, et al. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy. Urology 2007; 70: 257-262
18. Kassouf W, Agarwal PK, Herr HW, et al. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol 2008; 26: 121-126
19. Vieweg J, Gschwend JE, Herr HW, Fair WR,. Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol 1999; 161: 449-454
20. Novara G, Svatek RS, Karakiewicz PI, et al. Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. J Urol 2010; 183: 2165-2170
21. Lotan Y, Gupta A, Shariat SF, et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 2005; 23: 6533-6539
22. Shariat SF, Svatek RS, Tilki D, et al. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 2010; 105: 1402-1412
23. Rink M, Fajkovic H, Cha EK, et al. Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol 2012; 61: 854-855
24. Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD,. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001; 54: 774-781
25. Lerner SP, Skinner DG, Lieskovsky G, et al. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol 1993; 149: 758-765
26. Dotan ZA, Kavanagh K, Yossepowitch O, et al. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. J Urol 2007; 178: 2308-2313
27. Fajkovic H, Halpern JA, Cha EK, et al. Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol 2011; 29: 457-463
28. Bolenz C, Herrmann E, Bastian PJ, et al. Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial. BJU Int 2010; 106: 493-499
29. Rink M, Shariat SF,. Can we apply nomograms derived in the United States to European patients? Yes, we can! Eur Urol 2012; 61: 65-66
30. Vickers AJ, Elkin EB,. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 2006; 26: 565-574
31. Vickers AJ, Cronin AM, Kattan MW, et al. Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach. Cancer 2009; 115: 5460-5469
32. Svatek RS, Shariat SF, Lasky RE, et al. The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder. Clin Cancer Res 2010; 16: 4461-4467
33. Shariat SF, Roudier MP, Wilcox GE, et al. Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes. Cancer Res 2003; 63: 4662-4670
34. Vazina A, Dugi D, Shariat SF, Evans J, Link R, Lerner SP,. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 2004; 171: 1830-1834